Drugs Made In America Acquisition
DMAA · NASDAQ
$10.88−$0.005 (−0.05%)TodayMarket closed ·
Prev close $10.88
Who owns DMAA
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 62.7% of DMAA’s shares.
- Drugs Made In America Acquisition LLC17.3%
- Karpus Investment Management10.3%
- Mizuho Securities USA, LLC.8.5%
- Feis Equities LLC5.1%
- Next 6 largest institutions21.5%
- All other shareholders37.3%
| Holder | Shares | % of shares |
|---|---|---|
| Drugs Made In America Acquisition LLC | 4.19M | 17.25% |
| Karpus Investment Management | 2.51M | 10.33% |
| Mizuho Securities USA, LLC. | 2.07M | 8.52% |
| Feis Equities LLC | 1.23M | 5.08% |
| Polar Asset Management Partners Inc. | 1.15M | 4.72% |
| Glazer Capital, LLC | 999.90K | 4.12% |
| Wolverine Asset Management, LLC | 832.09K | 3.43% |
| Highbridge Capital Management, LLC | 809.05K | 3.33% |
| First Trust Capital Management L.P. | 786.46K | 3.24% |
| Heights Capital Management, Inc. | 648.08K | 2.67% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| First Trust Merger Arbitrage Fund | 1.93M | 7.95% |
| Merger Fund | 1.63M | 6.70% |
| First Trust Multi-Strategy Fund | 299.91K | 1.24% |
| Special Opportunities Fund, Inc. | 72.96K | 0.30% |
| Fidelity NASDAQ Composite Index Fund | 62.27K | 0.26% |
Short interest
Settled Sep 30, 2026
- Shares short
- 89.79K
- Days to cover
- 101.00
- % of shares outstanding
- 0.37%
- Average daily volume
- 889
- Change since last report
- −3.0%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.